Rohit Budhiraja1, Clete A Kushida2, Deborah A Nichols2, James K Walsh3, Richard D Simon4, Daniel J Gottlieb1,5, Stuart F Quan1,6. 1. Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Division of Sleep Medicine, Harvard Medical School, Boston, MA. 2. Stanford University Sleep Clinic and Center for Human Sleep Research, Redwood City, CA. 3. Sleep Medicine and Research Center, St. Luke's Hospital, Chesterfield, MO. 4. Providence St. Mary Medical Center, Walla Walla, Washington. 5. VA Boston Healthcare System, Boston, MA. 6. Arizona Respiratory Center, University of Arizona, Tucson, AZ.
Abstract
STUDY OBJECTIVES: To evaluate factors associated with continuous positive airway pressure (CPAP) adherence in patients with obstructive sleep apnea (OSA) in the Apnea Positive Pressure Long-term Efficacy Study (APPLES) cohort. METHODS: The data from a prospective 6-mo multicenter randomized controlled trial with 558 subjects randomized toactive CPAP and 547 to sham CPAP were analyzed to assess adherence to CPAP during first 2 mo (early period) and during months 5-6 (late period). RESULTS: Participants randomized to active CPAP had higher hours of nightly adherence compared to the sham CPAP group at both 2 (4.9 ± 2.0 h versus 4.07 ± 2.14 h, p < 0.001) and 6 mo (4.70 ± 2.08 h versus 3.41 ± 2.19 h, p < 0.001). Those assigned to sham CPAP were more likely to correctly identify their treatment group (70.0% versus 55.2%, p < 0.001). Irrespective of treatment group assignment, those who believed they were receiving active CPAP had higher hours of adherence than those who thought they were in the sham CPAP group at both 2 mo (4.91 ± 2.01 versus 4.17 ± 2.17, p < 0.001) and 6 mo (4.65 ± 2.10 versus 3.65 ± 2.22, p < 0.001). Among those randomized to active CPAP, older age was significantly related to CPAP use > 4 h per night. Presence of cardiovascular disorders was associated with higher hours of CPAP use, whereas presence of anxiety was associated with a trend toward lower hours of CPAP use. Presence of nasal congestion was associated with a decrease in mean daily CPAP use between the early and the late adherence period. The adherence during the week prior to a clinic visit was higher than the average adherence during the 2-mo period prior to the visit. CONCLUSIONS: Randomization to active therapy, belief that one is in the active treatment group, older age, and possibly presence of cardiovascular disorders are positively linked to CPAP adherence. Nasal congestion and anxiety are negatively associated with CPAP adherence. CPAP nightly usage increases as clinic visits approach.
RCT Entities:
STUDY OBJECTIVES: To evaluate factors associated with continuous positive airway pressure (CPAP) adherence in patients with obstructive sleep apnea (OSA) in the Apnea Positive Pressure Long-term Efficacy Study (APPLES) cohort. METHODS: The data from a prospective 6-mo multicenter randomized controlled trial with 558 subjects randomized to active CPAP and 547 to sham CPAP were analyzed to assess adherence to CPAP during first 2 mo (early period) and during months 5-6 (late period). RESULTS:Participants randomized to active CPAP had higher hours of nightly adherence compared to the sham CPAP group at both 2 (4.9 ± 2.0 h versus 4.07 ± 2.14 h, p < 0.001) and 6 mo (4.70 ± 2.08 h versus 3.41 ± 2.19 h, p < 0.001). Those assigned to sham CPAP were more likely to correctly identify their treatment group (70.0% versus 55.2%, p < 0.001). Irrespective of treatment group assignment, those who believed they were receiving active CPAP had higher hours of adherence than those who thought they were in the sham CPAP group at both 2 mo (4.91 ± 2.01 versus 4.17 ± 2.17, p < 0.001) and 6 mo (4.65 ± 2.10 versus 3.65 ± 2.22, p < 0.001). Among those randomized to active CPAP, older age was significantly related to CPAP use > 4 h per night. Presence of cardiovascular disorders was associated with higher hours of CPAP use, whereas presence of anxiety was associated with a trend toward lower hours of CPAP use. Presence of nasal congestion was associated with a decrease in mean daily CPAP use between the early and the late adherence period. The adherence during the week prior to a clinic visit was higher than the average adherence during the 2-mo period prior to the visit. CONCLUSIONS: Randomization to active therapy, belief that one is in the active treatment group, older age, and possibly presence of cardiovascular disorders are positively linked to CPAP adherence. Nasal congestion and anxiety are negatively associated with CPAP adherence. CPAP nightly usage increases as clinic visits approach.
Authors: Amy M Sawyer; Nalaka S Gooneratne; Carole L Marcus; Dafna Ofer; Kathy C Richards; Terri E Weaver Journal: Sleep Med Rev Date: 2011-06-08 Impact factor: 11.609
Authors: T E Weaver; N B Kribbs; A I Pack; L R Kline; D K Chugh; G Maislin; P L Smith; A R Schwartz; N M Schubert; K A Gillen; D F Dinges Journal: Sleep Date: 1997-04 Impact factor: 5.849
Authors: Clete A Kushida; Deborah A Nichols; Stuart F Quan; James L Goodwin; David P White; Daniel J Gottlieb; James K Walsh; Paula K Schweitzer; Christian Guilleminault; Richard D Simon; Eileen B Leary; Pamela R Hyde; Tyson H Holmes; Daniel A Bloch; Sylvan Green; Linda K McEvoy; Alan Gevins; William C Dement Journal: J Clin Sleep Med Date: 2006-07-15 Impact factor: 4.062
Authors: Rohit Budhiraja; Sairam Parthasarathy; Christopher L Drake; Thomas Roth; Imran Sharief; Pooja Budhiraja; Victoria Saunders; David W Hudgel Journal: Sleep Date: 2007-03 Impact factor: 5.849
Authors: Christopher N Schmickl; Christopher J Lettieri; Jeremy E Orr; Pamela DeYoung; Bradley A Edwards; Robert L Owens; Atul Malhotra Journal: Am J Respir Crit Care Med Date: 2020-12-01 Impact factor: 21.405
Authors: Andrey V Zinchuk; Nancy S Redeker; Jen-Hwa Chu; Jiasheng Liang; Carl Stepnowsky; Cynthia A Brandt; Dawn M Bravata; Andrew Wellman; Scott A Sands; Henry K Yaggi Journal: Am J Respir Crit Care Med Date: 2020-06-15 Impact factor: 21.405
Authors: Rohit Budhiraja; Clete A Kushida; Deborah A Nichols; James K Walsh; Richard D Simon; Daniel J Gottlieb; Stuart F Quan Journal: Eur Respir J Date: 2017-11-30 Impact factor: 16.671
Authors: Holger Woehrle; Michael Arzt; Andrea Graml; Ingo Fietze; Peter Young; Helmut Teschler; Joachim H Ficker Journal: BMC Pulm Med Date: 2018-12-05 Impact factor: 3.317
Authors: Andrey V Zinchuk; Jen-Hwa Chu; Jiasheng Liang; Yeliz Celik; Sara Op de Beeck; Nancy S Redeker; Andrew Wellman; H Klar Yaggi; Yüksel Peker; Scott A Sands Journal: Am J Respir Crit Care Med Date: 2021-09-15 Impact factor: 30.528